Cardiovascular Disease Outcomes Associated with Three Major Inflammatory Dermatologic Diseases: A Propensity-Matched Case Control Study

Overview

Journal Dermatol Ther (Heidelb)

Date 2016 Sep 24

PMID 27659680

Citations 12

Authors

Vincent D Marshall

Farah Moustafa

Spencer D Hawkins

Rajesh Balkrishnan

Steven R Feldman

Affiliations

Soon will be listed here.

Abstract

Introduction: Inflammation is an established component of cardiovascular disease (CVD) and an underlying factor of several dermatologic conditions including rosacea, atopic dermatitis, and psoriasis. Identifying potential associations between these dermatologic and cardiovascular diseases can better inform holistic healthcare approaches. The objective of this study was to determine whether rosacea, psoriasis or atopic dermatitis are independent risk factors for CVD 1 year following diagnosis.

Methods: Using a large commercial claims database of 21,801,147 lives, we employed a propensity-matched logistic regression to evaluate the association between diagnoses of rosacea, psoriasis, or atopic dermatitis and a 1-year risk of being diagnosed with cardiovascular disease. Control patients were matched based on health-care utilization, age and overall health status as defined by a modified Deyo-Charlson comorbidity index.

Results: The analysis included 2105 rosacea, 622 atopic dermatitis, 1536 psoriasis, and 4263 control patients. Compared to propensity-matched controls, the adjusted odds of cardiovascular disease were not higher in patients with rosacea (odds ratio: 0.894, p = 0.2713), atopic dermatitis (OR 1.032, p = 0.8489), or psoriasis (OR 1.087, p = 0.4210). In univariate analysis, the unadjusted odds of cardiovascular disease was higher in patients with psoriasis (OR 1.223, p = 0.0347).

Conclusions: Limitations of this study include the short follow-up period and inclusion of only commercially insured patients limit the generalizability of these findings. In this large study of patients with rosacea, atopic dermatitis, and psoriasis, we did not detect an increased 1-year risk of cardiovascular disease after adjusting for confounders.

Citing Articles

Genetic analyses reveal association between rosacea and cardiovascular diseases.

Gao Y, Xu C, Yan Q Sci Rep. 2025; 15(1):6657.

PMID: 39994418 PMC: 11850808. DOI: 10.1038/s41598-025-91240-4.

Incidence of Cardiovascular Disease After Atopic Dermatitis Development: A Nationwide, Population-Based Study.

Lee S, Kim H, Byun Y, Baek Y, Choi C, Kim J Allergy Asthma Immunol Res. 2023; 15(2):231-245.

PMID: 37021508 PMC: 10079521. DOI: 10.4168/aair.2023.15.2.231.

A mixed methods systematic review of digital interventions to support the psychological health and well-being of people living with dermatological conditions.

Hewitt R, Ploszajski M, Purcell C, Pattinson R, Jones B, Wren G Front Med (Lausanne). 2022; 9:1024879.

PMID: 36405626 PMC: 9669071. DOI: 10.3389/fmed.2022.1024879.

Investigating the association of atopic dermatitis with ischemic stroke and coronary heart disease: A mendelian randomization study.

Huang J, Gui Y, Wu J, Xie Y Front Genet. 2022; 13:956850.

PMID: 36110212 PMC: 9468876. DOI: 10.3389/fgene.2022.956850.

Association of Rosacea With Cardiovascular Disease: A Retrospective Cohort Study.

Choi D, Choi S, Choi S, Park S, Yoon H J Am Heart Assoc. 2021; 10(19):e020671.

PMID: 34558290 PMC: 8649155. DOI: 10.1161/JAHA.120.020671.

References

Solomon D, Goodson N, Katz J, Weinblatt M, Avorn J, Setoguchi S . Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis. 2006; 65(12):1608-12. PMC: 1798453. DOI: 10.1136/ard.2005.050377. View

Wakkee M, Thio H, Prens E, Sijbrands E, Neumann H . Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis. 2006; 190(1):1-9. DOI: 10.1016/j.atherosclerosis.2006.07.011. View

Su V, Chen T, Yeh C, Chou K, Hung M, Chu S . Atopic dermatitis and risk of ischemic stroke: a nationwide population-based study. Ann Med. 2014; 46(2):84-9. DOI: 10.3109/07853890.2013.870018. View

Duman N, Ersoy Evans S, Atakan N . Rosacea and cardiovascular risk factors: a case control study. J Eur Acad Dermatol Venereol. 2013; 28(9):1165-9. DOI: 10.1111/jdv.12234. View

Miller I, Ellervik C, Yazdanyar S, Jemec G . Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol. 2013; 69(6):1014-24. DOI: 10.1016/j.jaad.2013.06.053. View

Willerson J, Ridker P . Inflammation as a cardiovascular risk factor. Circulation. 2004; 109(21 Suppl 1):II2-10. DOI: 10.1161/01.CIR.0000129535.04194.38. View

Dhawan S, Quyyumi A . Rheumatoid arthritis and cardiovascular disease. Curr Atheroscler Rep. 2008; 10(2):128-33. DOI: 10.1007/s11883-008-0019-x. View

Kaplan R, Frishman W . Systemic inflammation as a cardiovascular disease risk factor and as a potential target for drug therapy. Heart Dis. 2002; 3(5):326-32. DOI: 10.1097/00132580-200109000-00009. View

Hua T, Chung P, Chen Y, Wu L, Chen Y, Hwang C . Cardiovascular comorbidities in patients with rosacea: A nationwide case-control study from Taiwan. J Am Acad Dermatol. 2015; 73(2):249-54. DOI: 10.1016/j.jaad.2015.04.028. View

10.

Alexandroff A, Pauriah M, Camp R, Lang C, Struthers A, Armstrong D . More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol. 2009; 161(1):1-7. DOI: 10.1111/j.1365-2133.2009.09281.x. View

11.

Egeberg A, Hansen P, Gislason G, Thyssen J . Assessment of the risk of cardiovascular disease in patients with rosacea. J Am Acad Dermatol. 2016; 75(2):336-9. DOI: 10.1016/j.jaad.2016.02.1158. View

12.

Mosca S, Gargiulo P, Balato N, DI Costanzo L, Parente A, Paolillo S . Ischemic cardiovascular involvement in psoriasis: a systematic review. Int J Cardiol. 2014; 178:191-9. DOI: 10.1016/j.ijcard.2014.10.092. View

13.

Evensen K, Slevolden E, Skagen K, Ronning O, Brunborg C, Krogstad A . Increased subclinical atherosclerosis in patients with chronic plaque psoriasis. Atherosclerosis. 2014; 237(2):499-503. DOI: 10.1016/j.atherosclerosis.2014.10.008. View

14.

Fischer L, Schlienger R, Matter C, Jick H, Meier C . Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol. 2004; 93(2):198-200. DOI: 10.1016/j.amjcard.2003.09.037. View

15.

Friedewald Jr V, Cather J, Gordon K, Kavanaugh A, Ridker P, Roberts W . The editor's roundtable: psoriasis, inflammation, and coronary artery disease. Am J Cardiol. 2008; 101(8):1119-26. DOI: 10.1016/j.amjcard.2007.11.032. View

16.

Neimann A, Shin D, Wang X, Margolis D, Troxel A, Gelfand J . Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006; 55(5):829-35. DOI: 10.1016/j.jaad.2006.08.040. View

17.

Sin D, Paul Man S . Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003; 107(11):1514-9. DOI: 10.1161/01.cir.0000056767.69054.b3. View

18.

Libby P . Inflammation in atherosclerosis. Nature. 2002; 420(6917):868-74. DOI: 10.1038/nature01323. View

19.

Wolfe F, Mitchell D, Sibley J, Fries J, Bloch D, Williams C . The mortality of rheumatoid arthritis. Arthritis Rheum. 1994; 37(4):481-94. DOI: 10.1002/art.1780370408. View

20.

Mehta N, Li K, Szapary P, Krueger J, Brodmerkel C . Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis. J Transl Med. 2013; 11:194. PMC: 3765699. DOI: 10.1186/1479-5876-11-194. View